Have any questions? 706-721-6582 or cts@augusta.edu
The purpose of this study is to find out if new treatment with durvalumab with or without olaparib when added to the standard of care chemotherapy and bevacizumab, could help defer or prevent relapse of your disease and whether these treatments cause any side effects.